Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. September 2023 03:24 ET | Quelle: Chr. Hansen Holding A/S

Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP

September 27, 2023 – Company announcement no. 8 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press...
04. September 2023 05:48 ET | Quelle: Chr. Hansen Holding A/S

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
06. Juli 2023 02:03 ET | Quelle: Chr. Hansen Holding A/S

Chr. Hansen Holding A/S Interim Report Q3 2022/23

July 6, 2023 – Company announcement no. 7 Strong execution by the organization drives solid Q3 results Statement by CEO Mauricio Graber: “The solid results for Q3 prove the strength of the Chr....
13. April 2023 02:02 ET | Quelle: Chr. Hansen Holding A/S

Chr. Hansen Holding A/S Interim Report Q2 2022/23

April 13, 2023 – Company announcement no. 6 A strong first half supporting the full-year outlook Statement by CEO Mauricio Graber: “The strong results for Q2 confirm the attractiveness of the...
30. März 2023 12:07 ET | Quelle: Chr. Hansen Holding A/S

Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
30. März 2023 11:58 ET | Quelle: Chr. Hansen Holding A/S

Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. ...
30. März 2023 07:11 ET | Quelle: Chr. Hansen Holding A/S

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30,...
28. März 2023 06:07 ET | Quelle: Chr. Hansen Holding A/S

Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
08. März 2023 02:05 ET | Quelle: Chr. Hansen Holding A/S

Notice to convene Extraordinary General Meeting

MARCH 8, 2023 – ANNOUNCEMENT NO. 4 An Extraordinary General Meeting of Chr. Hansen Holding A/S will be held on Thursday, March 30, 2023, at 5:00 p.m. CEST at The Hangar – Clarion...
08. März 2023 02:00 ET | Quelle: Chr. Hansen Holding A/S

Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...

Vorherige Seite

Nächste Seite